MSB 2.51% 97.0¢ mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-31

  1. 489 Posts.
    lightbulb Created with Sketch. 104
    not really have we proved batch consistency that’s the major stumbling block for me science needs to be repeatable
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.